IL162133A0 - Method of increasing protein expression, proteins and polynucleotides - Google Patents

Method of increasing protein expression, proteins and polynucleotides

Info

Publication number
IL162133A0
IL162133A0 IL16213302A IL16213302A IL162133A0 IL 162133 A0 IL162133 A0 IL 162133A0 IL 16213302 A IL16213302 A IL 16213302A IL 16213302 A IL16213302 A IL 16213302A IL 162133 A0 IL162133 A0 IL 162133A0
Authority
IL
Israel
Prior art keywords
amino acid
polynucleotides
proline
protein expression
proteins
Prior art date
Application number
IL16213302A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL162133A0 publication Critical patent/IL162133A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
IL16213302A 2001-11-30 2002-11-21 Method of increasing protein expression, proteins and polynucleotides IL162133A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34064801P 2001-11-30 2001-11-30
PCT/EP2002/013059 WO2003046160A2 (en) 2001-11-30 2002-11-21 Methods of increasing protein expression levels

Publications (1)

Publication Number Publication Date
IL162133A0 true IL162133A0 (en) 2005-11-20

Family

ID=23334343

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16213302A IL162133A0 (en) 2001-11-30 2002-11-21 Method of increasing protein expression, proteins and polynucleotides

Country Status (12)

Country Link
US (2) US7258997B2 (de)
EP (1) EP1448772B1 (de)
JP (1) JP2005535281A (de)
AT (1) ATE367438T1 (de)
AU (1) AU2002338947B2 (de)
CA (1) CA2466298A1 (de)
DE (1) DE60221273D1 (de)
DK (1) DK1448772T3 (de)
ES (1) ES2290337T3 (de)
IL (1) IL162133A0 (de)
PT (1) PT1448772E (de)
WO (1) WO2003046160A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1448772B1 (de) * 2001-11-30 2007-07-18 Applied Research Systems ARS Holding N.V. Verfahren zur steigerung der expression von menschlichen tnf-rezeptor
EP1697414A2 (de) * 2003-12-23 2006-09-06 Applied Research Systems ARS Holding N.V. Verfahren zur herstellung von den tumornekrosefaktor bindenden proteinen
US8722348B2 (en) 2008-05-28 2014-05-13 Wayne State University Method and composition for a protein transduction technology and its applications
PT2705143T (pt) 2011-05-02 2021-04-07 Univ Wayne State Tecnologia de células pluripotentes induzidas por proteínas e utilizações da mesma
US10076574B2 (en) 2013-10-25 2018-09-18 Wayne State University Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming
JP2022537052A (ja) * 2019-06-21 2022-08-23 カーナル バイオロジクス， インコーポレイテッド 操作された腫瘍選択的タンパク質発現
CA3169961A1 (en) * 2020-02-03 2021-08-12 Premas Biotech Private Limited Recombinant expression platform, constructs and methods for expression of difficult to express proteins (dte-ps)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE289350T1 (de) * 1989-04-21 2005-03-15 Amgen Inc Tnf-rezeptor, tnf bindende proteine und dafür kodierende dnas
CA2122923C (en) * 1991-11-25 1999-01-19 Roy L. Blank Compositions for regulating skin wrinkles and/or skin atrophy
IL107268A0 (en) * 1993-10-12 1994-01-25 Yeda Res & Dev Molecules influencing the shedding of the tnf receptor, their preparation and their use
EP1390497A2 (de) * 2001-05-25 2004-02-25 Genset Menschliche cdns und proteine und verwendungen davon
EP1448772B1 (de) * 2001-11-30 2007-07-18 Applied Research Systems ARS Holding N.V. Verfahren zur steigerung der expression von menschlichen tnf-rezeptor

Also Published As

Publication number Publication date
EP1448772A2 (de) 2004-08-25
WO2003046160A3 (en) 2003-07-31
JP2005535281A (ja) 2005-11-24
DK1448772T3 (da) 2007-11-19
CA2466298A1 (en) 2003-06-05
US20080014635A1 (en) 2008-01-17
AU2002338947A1 (en) 2003-06-10
WO2003046160A2 (en) 2003-06-05
US20050074840A1 (en) 2005-04-07
ES2290337T3 (es) 2008-02-16
US7258997B2 (en) 2007-08-21
EP1448772B1 (de) 2007-07-18
PT1448772E (pt) 2007-10-02
AU2002338947B2 (en) 2007-09-13
ATE367438T1 (de) 2007-08-15
DE60221273D1 (de) 2007-08-30

Similar Documents

Publication Publication Date Title
WO2002002627A3 (en) Interferon-like protein zcyto21
DE60323210D1 (en) Eukaryontische signalsequenzen für polypeptid-expr
EA199900939A1 (ru) Остеопротегерин-связывающие белки и рецепторы
MXPA03008715A (es) Reduccion de la inmunogenicidad de proteinas de fusion.
IL184112A0 (en) A method for producing polypeptides or proteins in a disulfide-bridged two-chain form
EP0722461A4 (de) Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird
ATE417595T1 (de) Keratin-bindende polypeptide
WO2002103024A3 (en) Stabilized proteins with engineered disulfide bonds
WO2002060951A3 (en) Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
UA97628C2 (ru) Способ получения fc-фрагмента иммуноглобулина, свободного от начального метионинового остатка, в массовом масштабе
EP0965637A4 (de) Fas ANTIGEN-DERIVATE
WO2000071714A3 (en) Methods of reducing factor viii clearance and compositions therefor
DE60335726D1 (de) Chromoprotein und fluoroproteine
SG166117A1 (en) Methods and compositions for treatment of interferon-resistant tumors
PE20020857A1 (es) Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras
IL162133A0 (en) Method of increasing protein expression, proteins and polynucleotides
ATE280827T1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
DK1098972T3 (da) Protein med lighed med neuroendokrinspecifikt protein samt cDNA kodende derfor
NZ508816A (en) Bactericidal/permeability-increasing protein (BPI) deletion analogs
NO971508L (no) Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
JP2005535281A5 (de)
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
EP0750040A3 (de) Varianten des Makrophagen-stimulierendes-Proteins und Verfahren zur ihrer Herstellung
EP1627063A4 (de) Induktion der blüte